Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,853 | -52,622 | -50,340 | -12,405 | -12,423 |
| Depreciation Amortization | 53,244 | 51,563 | 49,737 | 7,484 | 5,626 |
| Income taxes - deferred | -553 | -573 | -523 | 363 | -361 |
| Accounts receivable | 3,022 | 3,232 | 1,438 | 974 | 3,303 |
| Accounts payable and accrued liabilities | 1,503 | 1,774 | 1,472 | -1,785 | -283 |
| Other Working Capital | 6,591 | 6,301 | 3,512 | 65 | 658 |
| Other Operating Activity | -3,129 | -3,934 | -2,310 | 6,744 | 3,195 |
| Operating Cash Flow | $6,825 | $5,741 | $2,986 | $1,440 | $-285 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 1,919 | 1,919 |
| PPE Investments | -809 | -602 | -513 | -2,644 | -2,343 |
| Purchase Sale Intangibles | -455 | -314 | -170 | -619 | -454 |
| Other Investing Activity | -455 | -314 | -170 | -619 | -454 |
| Investing Cash Flow | $-1,264 | $-916 | $-683 | $-1,344 | $-878 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 8,800 | 8,800 |
| Debt Repayment | N/A | -2,000 | -1,000 | -8,573 | -2,550 |
| Common Stock Issued | 46 | 46 | N/A | 380 | 219 |
| Other Financing Activity | -3,786 | -508 | -204 | -738 | -5,243 |
| Financing Cash Flow | $-3,740 | $-2,462 | $-1,204 | $-131 | $1,226 |
| Exchange Rate Effect | 888 | 971 | 339 | -140 | 223 |
| Beginning Cash Position | 4,108 | 4,108 | 4,108 | 4,283 | 4,283 |
| End Cash Position | 6,817 | 7,442 | 5,546 | 4,108 | 4,569 |
| Net Cash Flow | $2,709 | $3,334 | $1,438 | $-175 | $286 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,825 | 5,741 | 2,986 | 1,440 | -285 |
| Capital Expenditure | -809 | -602 | -513 | -2,644 | -2,343 |
| Free Cash Flow | 6,016 | 5,139 | 2,473 | -1,204 | -2,628 |